Medical News

RSS

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

The brain is a coding machine: it translates physical inputs from the world into visual, olfactory, auditory, tactile perceptions via the mysterious language of its nerve cells and the networks which they form. Neural codes could in principle take many forms, but in regions forming bottlenecks for information flow or in areas important for memory, sparse codes are highly desirable.

16 May 2011

Continuous positive airway pressure reduces cardiovascular mortality in elderly OSA patients

Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain.

16 May 2011

With next election in mind, Medicare politics among the dynamics similar to 2010 congressional contests

Some news outlets report that "what goes around comes around" as many House Republicans are being reminded of the last election's raucous town hall meetings — this time, though, they are in the hot seat. Meanwhile, members of the GOP freshmen class have asked the White House to condemn liberal attacks on the Medicare proposal advanced by Rep. Paul Ryan, R-Wis.

16 May 2011

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of treatment.

16 May 2011

Loyola earns Joint Commission certification for heart pump therapy

Loyola University Hospital has been certified by the Joint Commission to begin implanting heart pumps known as left ventricular assist devices (LVADs) as permanent therapy for advanced heart failure.

16 May 2011

Researchers discover depression-related DNA region

Researchers at Washington University School of Medicine in St. Louis and King's College London have independently identified DNA on chromosome 3 that appears to be related to depression.

16 May 2011

Alzheimer's Association commends U.S. House Representatives for new legislation

As the leading advocacy, research and support organization for Alzheimer's disease, the Alzheimer's Association commends Representatives Christopher Smith and Edward Markey for their leadership in introducing the Alzheimer's Breakthrough Act (H.R.1897) in the U.S. House of Representatives.

16 May 2011

Roche initiates TB-403 Phase Ib/II study in glioblastoma multiforme

ThromboGenics and co-development partner BioInvent International announce today that their partner Roche has dosed the first patient in a Phase Ib/II study with the novel antibody anti-cancer agent TB-403 (RG7334).

16 May 2011

Study reveals crucial role of histone deacetylases in type 2 diabetes

A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.

16 May 2011

Scientists discover new class of compounds that selectively block 'serine hydrolases'

Scientists from The Scripps Research Institute have identified a class of compounds that could be a boon to basic research and drug discovery.

16 May 2011

New autism research findings presented at 10th annual IMFAR

Much about autism is unknown, but researchers from the University of Rochester Medical Center (URMC) are working to learn more about the neurodevelopmental disorder and its most effective treatments. A team of researchers from URMC joins researchers from across the world in San Diego this week for the 10th annual International Meeting for Autism Research (IMFAR).

16 May 2011

As consumers postpone care, health insurers make record profits

The nation's major health insurers are barreling into a third year of record profits, enriched in recent months by a lingering recessionary mind-set among Americans who are postponing or forgoing medical care. The UnitedHealth Group, one of the largest commercial insurers, told analysts that so far this year, insured hospital stays actually decreased in some instances.

16 May 2011

Computer games can improve patient's recovery from paralysis after stroke

Computer games are not just for kids. New research published in Journal of NeuroEngineering and Rehabilitation, a BioMed Central open access journal, shows that computer games can speed up and improve a patient's recovery from paralysis after a stroke.

16 May 2011

Young scientists receive Intel Foundation top prize for groundbreaking cancer work

Matthew Feddersen and Blake Marggraff from Lafayette, Calif. were awarded the top prize at the Intel International Science and Engineering Fair, a program of Society for Science & the Public. They received $75,000 and the Gordon E. Moore Award, in honor of the Intel co-founder and retired chairman and CEO, for developing a potentially more effective and less expensive cancer treatment that places tin metal near a tumor before radiation therapy.

16 May 2011

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

\VAYA Pharma announced the availability of Vayarin in pharmacies throughout North Carolina, South Carolina and Texas for children suffering with Attention-Deficit / Hyperactivity Disorder (ADHD).

16 May 2011

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Techulon, Inc. announced today that its Glycofect Discovery and Therapeutic Delivery Platform has been awarded United States patent protection. The patented invention provides a new class of non-viral transfection vectors based on synthetic carbohydrate containing polyamides that can be used for both in vivo and in vitro applications.

16 May 2011

Teva signs definitive agreement to acquire Taiyo

Teva Pharmaceutical Industries Ltd. announced today that it has signed a definitive agreement to acquire 57% of the shares in privately-held Taiyo Pharmaceutical Industry Co. Ltd. for $460 million in cash paid to private shareholders.

16 May 2011

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced results from a Phase 2 clinical trial of OPC-34712, a novel D2 dopamine partial agonist investigational product.

16 May 2011

CDRD, University of Ottawa sign affiliation agreement for drug development platform

The University of Ottawa and the Centre for Drug Research and Development (CDRD) today announced that they have signed an affiliation agreement that will allow researchers at the University of Ottawa to access CDRD's drug development infrastructure and expertise.

16 May 2011

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.

16 May 2011

Medical News

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

Continuous positive airway pressure reduces cardiovascular mortality in elderly OSA patients

With next election in mind, Medicare politics among the dynamics similar to 2010 congressional contests

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Loyola earns Joint Commission certification for heart pump therapy

Researchers discover depression-related DNA region

Alzheimer's Association commends U.S. House Representatives for new legislation

Roche initiates TB-403 Phase Ib/II study in glioblastoma multiforme

Study reveals crucial role of histone deacetylases in type 2 diabetes

Scientists discover new class of compounds that selectively block 'serine hydrolases'

New autism research findings presented at 10th annual IMFAR

As consumers postpone care, health insurers make record profits

Computer games can improve patient's recovery from paralysis after stroke

Young scientists receive Intel Foundation top prize for groundbreaking cancer work

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Teva signs definitive agreement to acquire Taiyo

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

CDRD, University of Ottawa sign affiliation agreement for drug development platform

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News